Correction to Nature https://doi.org/10.1038/s41586-018-0705-y, published online 07 November 2018.
In this Letter, author Ana C. Puhl was inadvertently omitted from the list of authors, with affiliation: Platform Technology & Science, GlaxoSmithKline, Collegeville, PA, USA. At the time this research was initiated, Ana C. Puhl held a post-doctoral position at GlaxoSmithKline through a fellowship awarded from the Brazilian government (the ‘Science without Borders’ programme), and the GlaxoSmithKline ‘Trust in Science’ programme. She performed crystallization trials and was instrumental in the determination of the structure of compounds 1 and 2 described in Figs. 1 and 2. In the ‘Author contributions’ section, the relevant sentence should read: “N.C. performed HDX studies and determined X-ray structures with assistance from L.W. and A.C.P.”. The Letter has been corrected online.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ramanjulu, J.M., Pesiridis, G.S., Yang, J. et al. Author Correction: Design of amidobenzimidazole STING receptor agonists with systemic activity. Nature 570, E53 (2019). https://doi.org/10.1038/s41586-019-1265-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41586-019-1265-5
This article is cited by
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
